Skip to main content
Clinical Trials/ITMCTR2100004427
ITMCTR2100004427
Recruiting
Phase 1

Multi-center randomized controlled study of Chuanhuang prescription combined with reduced glutathione regimen in 2-4 CKD with 1-2 grade AKI

ConditionsA on C

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
A on C
Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects meeting the diagnostic criteria of ckd 2\-4 and acute kidney injury grade 1\-2;
  • 2\. Subjects who meet the diagnostic criteria of TCM syndrome of spleen kidney deficiency and toxin stasis combination;
  • 3\. 24hu Pro \=2\.5g;
  • 4\. Subjects aged 18\-75 years old;
  • 5\. Volunteers to participate in this clinical trial and sign the informed consent.

Exclusion Criteria

  • 1\. Women who are pregnant or preparing for pregnancy and lactation;
  • 2\. Patients with serious primary diseases of other organs in urgent need of immediate treatment, or patients with consumption system diseases such as malignant tumor and active tuberculosis;
  • 3\. Patients with anorectal diseases not suitable for enema
  • 4\. Patients after renal transplantation;
  • 5\. Psychotic patients, unable to cooperate;
  • 6\. Subjects allergic to therapeutic drugs;
  • 7\. Subjects who are participating in other drug clinical trials or who have participated in other clinical trials within 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials